Danielle Brill
Stock Analyst at Truist Financial
(4.64)
# 837
Out of 4,429 analysts
382
Total ratings
54.3%
Success rate
13%
Average return
Main Sectors:
Stocks Rated by Danielle Brill
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IRON Disc Medicine | Maintained: Buy | n/a | $70.79 | - | 18 | Jun 16, 2026 | |
| DNTH Dianthus Therapeutics | Maintained: Buy | n/a | $82.49 | - | 8 | Jun 15, 2026 | |
| ARGX argenx SE | Maintained: Buy | n/a | $877.72 | - | 31 | Jun 9, 2026 | |
| PRAX Praxis Precision Medicines | Rated: Buy | $715 → $616 | $282.31 | +118.20% | 2 | Jun 2, 2026 | |
| CLYM Climb Bio | Maintained: Buy | n/a | $11.45 | - | 4 | Jun 2, 2026 | |
| APGE Apogee Therapeutics | Rated: Hold | $81 | $90.38 | -10.38% | 4 | May 28, 2026 | |
| VRTX Vertex Pharmaceuticals | Initiated Coverage: Buy | $542 | $451.63 | +20.01% | 6 | May 27, 2026 | |
| IMVT Immunovant | Maintained: Hold | $23 → $30 | $35.34 | -15.11% | 14 | May 22, 2026 | |
| PVLA Palvella Therapeutics | Maintained: Buy | n/a | $113.10 | - | 12 | May 21, 2026 | |
| WVE Wave Life Sciences | Maintained: Buy | n/a | $6.16 | - | 2 | May 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $56 | $37.34 | +49.97% | 2 | May 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $185 | $95.80 | +93.11% | 8 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $196.58 | - | 17 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $43 | $6.25 | +588.00% | 6 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $25.68 | - | 4 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 | $30.03 | +99.80% | 11 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $102 | $66.27 | +53.92% | 14 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $25 → $29 | $33.28 | -12.86% | 19 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $155 | $158.29 | -2.08% | 21 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $278.09 | - | 13 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $38 | $40.02 | -5.05% | 11 | Apr 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $8.99 | $46.29 | n/a | 23 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $7.80 | n/a | 3 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $21.62 | n/a | 19 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $79 | $54.69 | n/a | 2 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $150 | $17.53 | n/a | 36 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $78.98 | n/a | 21 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $51 | $34.16 | n/a | 3 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $52 → $50 | $52.91 | n/a | 2 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $23.31 | n/a | 2 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $6.76 | n/a | 19 | Jun 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24 → $10 | $5.59 | n/a | 5 | May 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $11.12 | n/a | 1 | Jun 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 → $45 | $10.65 | n/a | 2 | May 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $44.99 | n/a | 10 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $125 | $250.50 | n/a | 1 | Dec 16, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 → $5 | $17.69 | n/a | 5 | Nov 7, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $123.76 | n/a | 1 | Jul 26, 2016 |
Disc Medicine
Jun 16, 2026
Maintained: Buy
Price Target: n/a
Current: $70.79
Upside: -
Dianthus Therapeutics
Jun 15, 2026
Maintained: Buy
Price Target: n/a
Current: $82.49
Upside: -
argenx SE
Jun 9, 2026
Maintained: Buy
Price Target: n/a
Current: $877.72
Upside: -
Praxis Precision Medicines
Jun 2, 2026
Rated: Buy
Price Target: $715 → $616
Current: $282.31
Upside: +118.20%
Climb Bio
Jun 2, 2026
Maintained: Buy
Price Target: n/a
Current: $11.45
Upside: -
Apogee Therapeutics
May 28, 2026
Rated: Hold
Price Target: $81
Current: $90.38
Upside: -10.38%
Vertex Pharmaceuticals
May 27, 2026
Initiated Coverage: Buy
Price Target: $542
Current: $451.63
Upside: +20.01%
Immunovant
May 22, 2026
Maintained: Hold
Price Target: $23 → $30
Current: $35.34
Upside: -15.11%
Palvella Therapeutics
May 21, 2026
Maintained: Buy
Price Target: n/a
Current: $113.10
Upside: -
Wave Life Sciences
May 19, 2026
Maintained: Buy
Price Target: n/a
Current: $6.16
Upside: -
May 19, 2026
Maintained: Buy
Price Target: $56
Current: $37.34
Upside: +49.97%
May 18, 2026
Maintained: Buy
Price Target: $185
Current: $95.80
Upside: +93.11%
May 15, 2026
Maintained: Hold
Price Target: n/a
Current: $196.58
Upside: -
May 14, 2026
Maintained: Buy
Price Target: $43
Current: $6.25
Upside: +588.00%
May 14, 2026
Maintained: Buy
Price Target: n/a
Current: $25.68
Upside: -
May 11, 2026
Maintained: Buy
Price Target: $60
Current: $30.03
Upside: +99.80%
May 11, 2026
Reiterated: Buy
Price Target: $102
Current: $66.27
Upside: +53.92%
May 8, 2026
Maintained: Hold
Price Target: $25 → $29
Current: $33.28
Upside: -12.86%
May 7, 2026
Rated: Buy
Price Target: $155
Current: $158.29
Upside: -2.08%
May 1, 2026
Maintained: Buy
Price Target: n/a
Current: $278.09
Upside: -
Apr 12, 2026
Downgraded: Hold
Price Target: $38
Current: $40.02
Upside: -5.05%
Dec 10, 2024
Maintained: Buy
Price Target: $20 → $8.99
Current: $46.29
Upside: n/a
Nov 18, 2024
Reiterated: Buy
Price Target: $18
Current: $7.80
Upside: n/a
Oct 10, 2024
Initiated Coverage: Hold
Price Target: n/a
Current: $21.62
Upside: n/a
Oct 10, 2024
Initiated Coverage: Buy
Price Target: $79
Current: $54.69
Upside: n/a
Oct 10, 2024
Initiated Coverage: Buy
Price Target: $150
Current: $17.53
Upside: n/a
Oct 10, 2024
Initiated Coverage: Hold
Price Target: n/a
Current: $78.98
Upside: n/a
Oct 10, 2024
Initiated Coverage: Buy
Price Target: $51
Current: $34.16
Upside: n/a
Oct 10, 2024
Initiated Coverage: Buy
Price Target: $52 → $50
Current: $52.91
Upside: n/a
Oct 10, 2024
Initiated Coverage: Hold
Price Target: n/a
Current: $23.31
Upside: n/a
Jun 26, 2023
Downgraded: Hold
Price Target: n/a
Current: $6.76
Upside: n/a
May 16, 2022
Maintained: Buy
Price Target: $24 → $10
Current: $5.59
Upside: n/a
Jun 30, 2021
Initiated Coverage: Hold
Price Target: n/a
Current: $11.12
Upside: n/a
May 27, 2020
Maintained: Buy
Price Target: $35 → $45
Current: $10.65
Upside: n/a
Feb 13, 2020
Maintained: Hold
Price Target: n/a
Current: $44.99
Upside: n/a
Dec 16, 2019
Reiterated: Buy
Price Target: $125
Current: $250.50
Upside: n/a
Nov 7, 2019
Maintained: Hold
Price Target: $6 → $5
Current: $17.69
Upside: n/a
Jul 26, 2016
Downgraded: Hold
Price Target: n/a
Current: $123.76
Upside: n/a